San Diego-based Tentarix Biotherapeutics announced the closing of a $50 million Series A investment co-led by Versant Ventures and Samsara BioCapital. The funding will be…
Sanofi presented data from a Phase 2b long-term extension study (LTS) evaluating tolebrutinib in patients with relapsing forms of multiple sclerosis (RMS). The results showed that after 48…
ChemoCentryx announced the FDA has approved Tavneos (avacopan) as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (also known as…
New York-based IpiNovyx Bio announced the closing of a $10 million seed financing round. The financing was led by Viva BioInnovator (a Viva Biotech division) and included participation from Lilly,…
The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $480,000 to investigate the long-term effects of viral infections on autoimmunity. OMRF scientist…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
